Research Article
Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam
Table 2
Factors associated with lipodystrophy among HIV-infected patients in Dar es Salaam.
| | Characteristic | Lipodystrophy | value | | Present | Absent |
| | Age (years) | | | | | ≤30 | 3 (5.9) | 48 (94.1) | 0.003 | | 31–40 | 32 (16.5) | 162 (83.5) | | 41–50 | 37 (27.6) | 97 (72.4) | | >50 | 17 (25.4) | 50 (74.6) | | Missing | 6 (30.0) | 14 (70.0) | | Gender | | | | | Male | 31 (26.5) | 86 (73.5) | 0.058 | | Female | 64 (18.3) | 285 (81.7) | | Marital status | | | | | Married | 41 (18.7) | 178 (81.3) | 0.860 | | Single | 20 (22.5) | 69 (77.5) | | Divorced/separated | 17 (21.0) | 64 (79.0) | | Widowed | 17 (22.1) | 60 (77.9) | | Education level | | | | | No formal education | 6 (22.2) | 21 (77.8) | 0.484 | | Primary education | 68 (19.1) | 288 (80.9) | | Secondary education | 16 (23.5) | 52 (76.5) | | College/university | 5 (33.3) | 10 (66.7) | | HAAT use | | | | | On HAART | 86 (36.1) | 152 (63.9) | <0.001 | | HAART naïve | 9 (3.9) | 219 (96.1) | | Type of HAART | | | | | Nevirapine based regimen | 8 (25.8) | 23 (74.2) | <0.001 | | Efavirenz based regimen | 30 (25.4) | 88 (74.6) | | Stavudine based regimen | 46 (53.5) | 40 (46.5) | | Protease Inhibitor based regimen | 2 (66.7) | 1 (33.3) | | Duration of HAART use | | | | | HAART naïve | 9 (3.9) | 219 (96.1) | <0.001 | | 24 months | 23 (38.3) | 37 (61.7) | | 24–48 months | 51 (34.2) | 98 (65.8) | | >48 months | 12 (41.4) | 17 (58.6) | | Body Mass Index (BMI) | | | | | Underweight | 16 (27.6) | 42 (72.4) | 0.048 | | Normal weight | 51 (21.7) | 184 (78.3) | | Overweight | 23 (20.9) | 87 (79.1) | | Obese | 5 (8.1) | 57 (91.9) | | Central obesity | | | | | No | 59 (19.6) | 242 (80.4) | 0.630 | | Yes | 36 (22.0) | 128 (78.0) |
|
|
BMI: Body Mass Index; HAART: Highly Active Antiretroviral Therapy.
|
